- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-2-mer
- Ligands
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 26 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
PCW.2: 5 residues within 4Å:- Chain A: F.506, G.793
- Chain D: V.595
- Chain F: M.11
- Ligands: PCW.7
Ligand excluded by PLIPPCW.3: 11 residues within 4Å:- Chain A: Y.854, E.856, K.993, Y.994, G.995, W.996, A.999, F.1000, A.1002, I.1003
- Ligands: AJP.6
Ligand excluded by PLIPPCW.4: 4 residues within 4Å:- Chain A: S.918, F.922
- Ligands: CLR.5, PCW.15
Ligand excluded by PLIPPCW.7: 12 residues within 4Å:- Chain A: G.504, F.506, L.509, W.517, V.521, Y.524, L.572, F.575, I.789
- Chain D: G.594
- Ligands: PCW.2, AJP.6
Ligand excluded by PLIPPCW.8: 4 residues within 4Å:- Chain A: E.895, R.917, T.920, P.921
Ligand excluded by PLIPPCW.9: 7 residues within 4Å:- Chain A: P.539, R.585, L.587
- Chain B: F.565, E.804, Y.807
- Ligands: PCW.14
Ligand excluded by PLIPPCW.10: 2 residues within 4Å:- Chain A: I.942, R.943
Ligand excluded by PLIPPCW.13: 15 residues within 4Å:- Chain A: V.595, F.598
- Chain B: F.506, L.509, Y.514, W.517, V.521, Y.524, F.565, L.568, L.572, F.575, M.576, I.789
- Ligands: PCW.15
Ligand excluded by PLIPPCW.14: 9 residues within 4Å:- Chain B: F.532, R.536, I.564
- Chain E: V.69, S.73, I.74, L.77, L.80
- Ligands: PCW.9
Ligand excluded by PLIPPCW.15: 6 residues within 4Å:- Chain A: V.595
- Chain B: F.506
- Ligands: PCW.4, CLR.5, PCW.13, PCW.16
Ligand excluded by PLIPPCW.16: 2 residues within 4Å:- Ligands: CLR.5, PCW.15
Ligand excluded by PLIPPCW.18: 5 residues within 4Å:- Chain B: V.595
- Chain C: F.506, Y.788
- Chain E: M.11
- Ligands: PCW.23
Ligand excluded by PLIPPCW.19: 10 residues within 4Å:- Chain C: Y.854, E.856, K.993, Y.994, G.995, W.996, F.1000, A.1002, I.1003
- Ligands: AJP.22
Ligand excluded by PLIPPCW.20: 4 residues within 4Å:- Chain C: S.918, F.922
- Ligands: CLR.21, PCW.30
Ligand excluded by PLIPPCW.23: 13 residues within 4Å:- Chain B: G.594, F.598
- Chain C: G.504, F.506, L.509, W.517, V.521, Y.524, L.572, F.575, I.789
- Ligands: PCW.18, AJP.22
Ligand excluded by PLIPPCW.24: 3 residues within 4Å:- Chain C: E.895, R.917, P.921
Ligand excluded by PLIPPCW.25: 9 residues within 4Å:- Chain C: P.539, R.585, S.586, L.587
- Chain D: F.565, L.568, E.804, Y.807
- Ligands: PCW.29
Ligand excluded by PLIPPCW.26: 1 residues within 4Å:- Chain C: R.943
Ligand excluded by PLIPPCW.28: 15 residues within 4Å:- Chain C: V.595, F.598
- Chain D: F.506, L.509, Y.514, W.517, V.521, Y.524, F.565, L.568, W.569, L.572, F.575, I.789
- Ligands: PCW.30
Ligand excluded by PLIPPCW.29: 10 residues within 4Å:- Chain D: F.532, R.536, I.564
- Chain F: V.69, P.70, S.73, I.74, L.77, L.80
- Ligands: PCW.25
Ligand excluded by PLIPPCW.30: 5 residues within 4Å:- Chain D: F.506
- Ligands: PCW.20, CLR.21, PCW.28, PCW.31
Ligand excluded by PLIPPCW.31: 2 residues within 4Å:- Ligands: CLR.21, PCW.30
Ligand excluded by PLIPPCW.32: 1 residues within 4Å:- Chain E: L.150
Ligand excluded by PLIPPCW.33: 3 residues within 4Å:- Chain E: Y.151, V.154, V.158
Ligand excluded by PLIPPCW.34: 1 residues within 4Å:- Chain F: L.150
Ligand excluded by PLIPPCW.35: 3 residues within 4Å:- Chain F: Y.151, V.154, V.158
Ligand excluded by PLIP- 2 x CLR: CHOLESTEROL(Non-covalent)
CLR.5: 11 residues within 4Å:- Chain A: L.959, L.962, S.963, V.966, L.970
- Chain B: Y.788, V.791, G.792
- Ligands: PCW.4, PCW.15, PCW.16
5 PLIP interactions:4 interactions with chain A, 1 interactions with chain B- Hydrophobic interactions: A:L.959, A:L.962, A:V.966, A:L.970, B:Y.788
CLR.21: 11 residues within 4Å:- Chain C: L.959, L.962, S.963, V.966, L.970
- Chain D: Y.788, V.791, G.792
- Ligands: PCW.20, PCW.30, PCW.31
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain D- Hydrophobic interactions: C:L.959, C:L.962, C:V.966, C:L.970, D:Y.788
- 2 x AJP: Digitonin(Non-covalent)
AJP.6: 7 residues within 4Å:- Chain A: Y.514, M.518, V.521, F.522, L.1006
- Ligands: PCW.3, PCW.7
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:Y.514, A:M.518, A:L.1006
- Hydrogen bonds: A:Y.514, A:Y.514
AJP.22: 8 residues within 4Å:- Chain C: Y.514, W.517, M.518, V.521, F.522, L.1006
- Ligands: PCW.19, PCW.23
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:Y.514, C:Y.514, C:M.518, C:V.521, C:L.1006
- Hydrogen bonds: C:Y.514
- 1 x SPD: SPERMIDINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Modulation of GluA2-gamma 5 synaptic complex desensitization, polyamine block and antiepileptic perampanel inhibition by auxiliary subunit cornichon-2. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-09-06
- Peptides
- Glutamate receptor 2, Voltage-dependent calcium channel gamma-5 subunit chimera: ABCD
Protein cornichon homolog 2: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-2-mer
- Ligands
- 4 x ZK1: {[7-morpholin-4-yl-2,3-dioxo-6-(trifluoromethyl)-3,4-dihydroquinoxalin-1(2H)-yl]methyl}phosphonic acid(Non-covalent)
- 26 x PCW: 1,2-DIOLEOYL-SN-GLYCERO-3-PHOSPHOCHOLINE(Non-covalent)(Non-functional Binders)
- 2 x CLR: CHOLESTEROL(Non-covalent)
- 2 x AJP: Digitonin(Non-covalent)
- 1 x SPD: SPERMIDINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Modulation of GluA2-gamma 5 synaptic complex desensitization, polyamine block and antiepileptic perampanel inhibition by auxiliary subunit cornichon-2. Nat.Struct.Mol.Biol. (2023)
- Release Date
- 2023-09-06
- Peptides
- Glutamate receptor 2, Voltage-dependent calcium channel gamma-5 subunit chimera: ABCD
Protein cornichon homolog 2: EF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
F - Membrane
-
We predict this structure to be a membrane protein.